Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRSF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZCCHC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FSTL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COBL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
HSPA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADCY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100128909 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
IPO8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMSAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH3BP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BEST3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on